[1] 国家卫生健康委办公厅,国家中医药管理局办公室.新型冠状病毒肺炎诊疗方案(试行第六版)[EB/OL].(2020-02-18)[2020-02-19].http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2/files/b218cfeb1bc54639af227f922bf6b817.pdf [2] 武汉市卫生健康委员会.武汉市卫健康委关于当前我市肺炎疫情的情况通报[EB/OL].(2019-12-31)[2020-01-30].http://wjw.wuhan.gov.cn/front/web/showDetail/2019123108989. [3] Chan JF, Yuan SF, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission:a study of a family cluster [J]. Lancet, 2020, 395(10223):514-523. [4] WHO:Surveillance case definitions for human infection with novel coronavirus(nCoV)[EB/OL].(2020-01-15)[2020-01-30].https://www.who.int/internal-publications-detail/surveillance-case-definitions-for-human-infection-withnovel-coronavirus-(ncov). [5] Ji W, Wang W, Zhao XF, et al. Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human [J]. J Med Virol, 2020. [6] Li Q, Guan XH, Wu P, et al. Early transmission dynamics in Wuhan,China,of novel coronavirus-infected pneumonia [J]. N Engl J Med, 2020, 382(13):1199-1207. [7] 华成舸,刘治清,王晴,等.从新型冠状病毒肺炎疫情防控看传染病流行期口腔门诊管理策略[J].华西口腔医学杂志,2020,38(2):117-121. [8] Munster VJ, Koopmans M, Van DN, et al. A novel coronavirus emerging in china-key questions for impact assessment [J]. N Engl J Med, 2020, 382(8):692-694. [9] Huang CL, Wang YM, Li XW, et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan,China [J]. Lancet, 2020, 395(10223):497-506. [10] 中华人民共和国中央人民政府.中华人民共和国国家卫生健康委员会公告2020年第1号[EB/OL].(2020-01-20)[2020-01-21].http://www.gov.cn/xinwen/2020-01/21/content_5471158.htm. [11] 王新燕,吴杰,鲁新华,等.河南省新型冠状病毒(2019-nCoV)感染孕产妇管理策略建议[J].郑州大学学报郑州大学学报(医学版),2020. [12] 葛慧青,代冰,徐培峰,等.新型冠状病毒肺炎患者呼吸机使用感控管理专家共识[J].中国呼吸与危重监护杂志,2020,19(2):1-4. [13] 李太生,曹玮,翁利,等.北京协和医院关于“新型冠状病毒感染的肺炎”诊疗建议方案(V2.0)[J].协和医学杂志,2020:1-5. [14] 周晓平,罗腾达.某三级传染病院医务人员职业暴露调查及防护对策[J].中国感染控制杂志,2012,11(2):143-145. |